Case number 2021-1609
Roche Diagnostics Corporation v. Meso Scale Diagnostics, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 16, 2022 | 45 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [849891] [21-1609, 21-1633]. --[Edited 05/16/2022 by MVH to correct originating tribunal section] [MVH] [Entered: 05/16/2022 10:29 AM] (1) |
| Apr 10, 2022 | 0 | ROCHE DIAGNOSTICS CORPORATION v. MESO SCALE DIAGNOSTICS, LLC [OPINION] [precedential] (0) |
| Apr 8, 2022 | 44 | JUDGMENT. AFFIRMED-IN-PART, REVERSED-IN-PART, VACATED-IN-PART, AND REMANDED. Terminated on the merits after oral argument. COSTS: Each Side Bears Its Own Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [841887] [21-1609, 21-1633] [MVH] [Entered: 04/08/2022 10:25 AM] (1) |
| Apr 8, 2022 | 43 | OPINION filed for the court by Newman, Circuit Judge; Prost, Circuit Judge and Taranto, Circuit Judge. Newman, Circuit Judge, dissenting. Precedential Opinion. Service as of this date by the Clerk of Court. [841884] [21-1609, 21-1633] [MVH] [Entered: 04/08/2022 10:24 AM] (38) |
| Nov 2, 2021 | 42 | Submitted after ORAL ARGUMENT to Panel: Newman, Circuit Judge; Prost, Circuit Judge and Taranto, Circuit Judge.Arguing counsel: James McKeown for BioVeris Corporation and Roche Diagnostics Corporation and Mr. John Hughes for Meso Scale Diagnostics, LLC.Oral Argument Audio available here. [809742] [JCP] [Entered: 11/02/2021 02:38 PM] (0) |
| Oct 20, 2021 | 41 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 10/20/2021 by email. [807138] [21-1609] [James McKeown] [Entered: 10/20/2021 05:15 PM] (43) |
| Oct 15, 2021 | 40 | Response to notice of oral argument from Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 10/15/2021 by email. [806050] [21-1609] [James McKeown] [Entered: 10/15/2021 02:09 PM] (3) |
| Oct 15, 2021 | 39 | Certification of Compliance with Revised Protocols for In-Person Argument for Cross-Appellant Meso Scale Diagnostics, LLC. Service: 10/15/2021 by email. [805949] [21-1609] [John Hughes] [Entered: 10/15/2021 11:28 AM] (2) |
| Oct 15, 2021 | 38 | Response to notice of oral argument from Cross-Appellant Meso Scale Diagnostics, LLC. Service: 10/15/2021 by email. [805947] [21-1609] [John Hughes] [Entered: 10/15/2021 11:25 AM] (1) |
| Sep 21, 2021 | 37 | NOTICE OF ORAL ARGUMENT. Panel: 2111D. Case scheduled November 2, 2021. Response to Notice of Oral Argument due: 10/15/2021. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [800944] [MVH] [Entered: 09/21/2021 07:22 PM] (2) |
| Sep 9, 2021 | 36 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The name of the attorney who electronically signed Meso Scale Diagnostics, LLC's conflict notice [33] does not match the name of the attorney who electronically filed the document. CORRECTION: Please ensure future electronic signatures comply with Fed. Cir. R. 25(g). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [798156] [MJL] [Entered: 09/09/2021 04:55 PM] (0) |
| Sep 9, 2021 | 35 | The following conflict dates submitted by John Hughes for Meso Scale Diagnostics, LLC have been accepted by the court: 01/10/2022, 01/11/2022, 01/12/2022, 01/13/2022, 01/14/2022. [798149] [MJL] [Entered: 09/09/2021 04:50 PM] (0) |
| Aug 30, 2021 | 33 | Notice from Cross-Appellant Meso Scale Diagnostics, LLC regarding conflicts with oral argument. Service: 08/30/2021 by clerk. [796082] [21-1609] [Steven Derringer] [Entered: 08/30/2021 04:22 PM] (2) |
| Aug 30, 2021 | 32 | Notice from Appellants Roche Diagnostics Corporation and BioVeris Corporation regarding conflicts with oral argument. None. Service: 08/30/2021 by email. [795922] [21-1609] [James McKeown] [Entered: 08/30/2021 11:35 AM] (1) |
| Aug 26, 2021 | 34 | 6 paper copies of Doc. No. [23], [15] received from Appellants BioVeris Corporation and Roche Diagnostics Corporation. [796569] [VDW] [Entered: 09/01/2021 11:33 AM] (0) |
| Aug 26, 2021 | 31 | 6 paper copies of Doc. No. [21] received from Appellants BioVeris Corporation and Roche Diagnostics Corporation. [795800]--[Edited 08/27/2021 by JAL to change filed date] [EKD] [Entered: 08/27/2021 03:45 PM] (0) |
| Aug 26, 2021 | 30 | 6 paper copies of Doc. No. [20], [22] received from Cross-Appellant Meso Scale Diagnostics, LLC. [795799]--[Edited 08/27/2021 by JAL to change filed date] [EKD] [Entered: 08/27/2021 03:44 PM] (0) |
| Aug 23, 2021 | 29 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [794620] [KMH] [Entered: 08/23/2021 12:20 PM] (0) |
| Aug 23, 2021 | 28 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [794617] [KMH] [Entered: 08/23/2021 12:17 PM] (1) |
| Aug 19, 2021 | 27 | Certificate of Compliance with Fed. Cir. 25.1(c)(2)(A) for Cross-Appellant Meso Scale Diagnostics, LLC. Service: 08/19/2021 by email. [793959] [21-1609] [Steven Derringer] [Entered: 08/19/2021 11:54 AM] (2) |
| Aug 19, 2021 | 26 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants BioVeris Corporation, Roche Diagnostics Corporation and Cross-Appellant Meso Scale Diagnostics, LLC. Service: 08/19/2021 by email. [793872] [21-1609] [James McKeown] [Entered: 08/19/2021 09:21 AM] (2) |
| Aug 19, 2021 | 25 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 08/19/2021 by email. [793868] [21-1609] [James McKeown] [Entered: 08/19/2021 09:18 AM] (2) |
| Aug 17, 2021 | 23 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 08/17/2021 by email. [793367]--[Edited 08/23/2021 by KMH - compliance review complete] [James McKeown] [Entered: 08/17/2021 01:20 PM] (0) |
| Aug 17, 2021 | 24 | MODIFIED ENTRY: APPENDIX FILED by Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 08/17/2021 by email. [793370] --[Edited 08/23/2021 by KMH - compliance review complete] [James McKeown] [Entered: 08/17/2021 01:30 PM] (2464) |
| Aug 10, 2021 | 22 | MODIFIED ENTRY: REPLY BRIEF FILED by Cross-Appellant Meso Scale Diagnostics, LLC. Service: 08/10/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [791729] --[Edited 08/11/2021 by KMH - compliance review complete] [Steven Derringer] [Entered: 08/10/2021 02:06 PM] (24) |
| Jul 20, 2021 | 21 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 07/20/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [787305] --[Edited 07/22/2021 by KMH - compliance review complete] [James McKeown] [Entered: 07/20/2021 12:02 PM] (58) |
| Jun 10, 2021 | 20 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Cross-Appellant Meso Scale Diagnostics, LLC. Service: 06/10/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [779645] --[Edited 06/16/2021 by KMH - compliance review complete] [Steven Derringer] [Entered: 06/10/2021 10:32 PM] (88) |
| May 13, 2021 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file brief [18] filed by Cross-Appellant Meso Scale Diagnostics, LLC. The response brief is due 06/10/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [774683] [KMH] [Entered: 05/13/2021 09:16 AM] (0) |
| May 11, 2021 | 18 | MOTION of Cross-Appellant Meso Scale Diagnostics, LLC to extend the time to 06/10/2021 to file brief. Service: 05/11/2021 by email. [774367] [21-1609] [Steven Derringer] [Entered: 05/11/2021 04:33 PM] (8) |
| Apr 29, 2021 | 17 | Entry of appearance for Anastasiya Maione as counsel for Cross-Appellant Meso Scale Diagnostics, LLC. Service: 04/29/2021 by email. [772103] [21-1609] [Anastasiya Maione] [Entered: 04/29/2021 02:48 PM] (1) |
| Apr 14, 2021 | 16 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 04/14/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [768627] --[Edited 04/19/2021 by KMH - compliance review complete] [James McKeown] [Entered: 04/14/2021 03:24 PM] (264) |
| Apr 14, 2021 | 15 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 04/14/2021 by email. [768626]--[Edited 04/19/2021 by KMH - compliance review complete] [James McKeown] [Entered: 04/14/2021 03:22 PM] (0) |
| Mar 11, 2021 | 14 | **TEXT ONLY** ORDER granting motion to extend time to file brief [13] filed by Appellants Roche Diagnostics Corporation and BioVeris Corporation. The opening brief is due 04/15/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [761546] [KMH] [Entered: 03/11/2021 09:22 AM] (0) |
| Mar 10, 2021 | 13 | MOTION of Appellants Roche Diagnostics Corporation and BioVeris Corporation to extend the time to 04/15/2021 to file brief. Service: 03/10/2021 by clerk, email. [761479] [21-1609] [James McKeown] [Entered: 03/10/2021 04:27 PM] (8) |
| Mar 5, 2021 | 12 | Entry of appearance for Eric L. Maassen as counsel for Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 03/05/2021 by email. [760301] [21-1609] [Eric Maassen] [Entered: 03/05/2021 11:13 AM] (1) |
| Feb 19, 2021 | 11 | Corrected Entry of appearance for Steven E. Derringer, John M. Hughes, Nosson D. Knobloch and Daniel C. Taylor as counsel for Cross-Appellant Meso Scale Diagnostics, LLC. Service: 02/19/2021 by email. [757389] [21-1609] [Steven Derringer] [Entered: 02/19/2021 01:24 PM] (2) |
| Feb 19, 2021 | 10 | NOTICE OF NON-COMPLIANCE: The submission of Cross-Appellant Meso Scale Diagnostics, LLC, Entry of Appearance [6], is not in compliance with the rules of this court (see attached). Compliant document due on 02/26/2021. Service as of this date by the Clerk of Court. [757259] [KMH] [Entered: 02/19/2021 09:09 AM] (2) |
| Feb 16, 2021 | 9 | Docketing Statement for the Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 02/16/2021 by email. [756485] [21-1609] [James McKeown] [Entered: 02/16/2021 05:37 PM] (2) |
| Feb 16, 2021 | 8 | Certificate of Interest for Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 02/16/2021 by email. [756484] [21-1609] [James McKeown] [Entered: 02/16/2021 05:36 PM] (3) |
| Feb 16, 2021 | 7 | Entry of appearance for James T. McKeown; Jeffrey N. Costakos; Kimberly K. Dodd as counsel for Appellants BioVeris Corporation and Roche Diagnostics Corporation. Service: 02/16/2021 by email. [756483] [21-1609] [James McKeown] [Entered: 02/16/2021 05:35 PM] (2) |
| Feb 16, 2021 | 6 | Entry of appearance for Steven E. Derringer, John M. Hughes, Nosson D. Knobloch, Daniel C. Taylor, Anastasiya Maione as counsel for Cross-Appellant Meso Scale Diagnostics, LLC. Service: 02/16/2021 by email. [756349] [21-1609] [Steven Derringer] [Entered: 02/16/2021 03:02 PM] (2) |
| Feb 16, 2021 | 5 | Docketing Statement for the Cross-Appellant Meso Scale Diagnostics, LLC. Service: 02/16/2021 by email. [756345] [21-1609] [Steven Derringer] [Entered: 02/16/2021 03:00 PM] (2) |
| Feb 16, 2021 | 4 | Certificate of Interest for Cross-Appellant Meso Scale Diagnostics, LLC. Service: 02/16/2021 by email. [756342] [21-1609] [Steven Derringer] [Entered: 02/16/2021 02:57 PM] (3) |
| Feb 8, 2021 | 3 | Official caption revised to reflect 21-1633 Cross-Appeal. (see attached). Service as of this date by the Clerk of Court. [754409] [KMH] [Entered: 02/08/2021 10:13 AM] (2) |
| Feb 8, 2021 | 2 | Note to File: The following cases are consolidated: 21-1609 Lead with 21-1633 Cross-Appeal. The parties must file all documents in the lead appeal only. [754407] [21-1609, 21-1633] [KMH] [Entered: 02/08/2021 10:13 AM] (0) |
| Feb 2, 2021 | 1 | Appeal docketed. Received: 01/20/2021. [753435]Entry of Appearance is due 02/16/2021. Certificate of Interest is due 02/16/2021. Docketing Statement is due 02/16/2021. Appellant's brief is due 04/05/2021. [KMH] [Entered: 02/02/2021 02:54 PM] (41) |
